AMERICAN WELL CORP-CLASS A (AMWL) Fundamental Analysis & Valuation
NYSE:AMWL • US03044L2043
Current stock price
5.51 USD
-0.04 (-0.72%)
At close:
5.62 USD
+0.11 (+2%)
After Hours:
This AMWL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. AMWL Profitability Analysis
1.1 Basic Checks
- In the past year AMWL has reported negative net income.
- AMWL had a negative operating cash flow in the past year.
- In the past 5 years AMWL always reported negative net income.
- AMWL had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of -29.56%, AMWL is in line with its industry, outperforming 45.71% of the companies in the same industry.
- AMWL has a Return On Equity of -40.62%. This is comparable to the rest of the industry: AMWL outperforms 48.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.56% | ||
| ROE | -40.62% | ||
| ROIC | N/A |
ROA(3y)-63.93%
ROA(5y)-45.24%
ROE(3y)-84.79%
ROE(5y)-58.8%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- AMWL has a Gross Margin (53.79%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of AMWL has grown nicely.
- AMWL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.79% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.48%
GM growth 5Y6.88%
2. AMWL Health Analysis
2.1 Basic Checks
- AMWL does not have a ROIC to compare to the WACC, probably because it is not profitable.
- AMWL has more shares outstanding than it did 1 year ago.
- The number of shares outstanding for AMWL has been reduced compared to 5 years ago.
- AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- Based on the Altman-Z score of -7.84, we must say that AMWL is in the distress zone and has some risk of bankruptcy.
- AMWL has a worse Altman-Z score (-7.84) than 85.71% of its industry peers.
- AMWL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -7.84 |
ROIC/WACCN/A
WACC8.94%
2.3 Liquidity
- AMWL has a Current Ratio of 3.37. This indicates that AMWL is financially healthy and has no problem in meeting its short term obligations.
- AMWL has a better Current ratio (3.37) than 80.00% of its industry peers.
- A Quick Ratio of 3.35 indicates that AMWL has no problem at all paying its short term obligations.
- With a decent Quick ratio value of 3.35, AMWL is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.37 | ||
| Quick Ratio | 3.35 |
3. AMWL Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 52.57% over the past year.
- The Revenue has decreased by -1.98% in the past year.
- The Revenue has been growing slightly by 0.33% on average over the past years.
EPS 1Y (TTM)52.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.13%
Revenue 1Y (TTM)-1.98%
Revenue growth 3Y-3.47%
Revenue growth 5Y0.33%
Sales Q2Q%-22.11%
3.2 Future
- The Earnings Per Share is expected to grow by 11.10% on average over the next years. This is quite good.
- Based on estimates for the next years, AMWL will show a decrease in Revenue. The Revenue will decrease by -1.60% on average per year.
EPS Next Y34.92%
EPS Next 2Y23.79%
EPS Next 3Y18.72%
EPS Next 5Y11.1%
Revenue Next Year-19.18%
Revenue Next 2Y-8.22%
Revenue Next 3Y-4.1%
Revenue Next 5Y-1.6%
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. AMWL Valuation Analysis
4.1 Price/Earnings Ratio
- AMWL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year AMWL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- AMWL's earnings are expected to grow with 18.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y18.72%
5. AMWL Dividend Analysis
5.1 Amount
- AMWL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
AMWL Fundamentals: All Metrics, Ratios and Statistics
5.51
-0.04 (-0.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)02-12 2026-02-12/amc
Earnings (Next)04-29 2026-04-29/amc
Inst Owners39.12%
Inst Owner Change0%
Ins Owners4.22%
Ins Owner Change1.36%
Market Cap91.19M
Revenue(TTM)249.32M
Net Income(TTM)-95.70M
Analysts70.67
Price Target6.63 (20.33%)
Short Float %2.3%
Short Ratio3.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.58%
Min EPS beat(2)-9.03%
Max EPS beat(2)16.19%
EPS beat(4)3
Avg EPS beat(4)17.14%
Min EPS beat(4)-9.03%
Max EPS beat(4)31.2%
EPS beat(8)6
Avg EPS beat(8)10.13%
EPS beat(12)7
Avg EPS beat(12)-7.06%
EPS beat(16)10
Avg EPS beat(16)-4.37%
Revenue beat(2)2
Avg Revenue beat(2)2.02%
Min Revenue beat(2)1.14%
Max Revenue beat(2)2.89%
Revenue beat(4)4
Avg Revenue beat(4)5.4%
Min Revenue beat(4)1.14%
Max Revenue beat(4)8.93%
Revenue beat(8)5
Avg Revenue beat(8)2.14%
Revenue beat(12)5
Avg Revenue beat(12)0.15%
Revenue beat(16)5
Avg Revenue beat(16)-0.22%
PT rev (1m)0%
PT rev (3m)-20.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.58%
EPS NY rev (1m)0%
EPS NY rev (3m)8.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-10.95%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-17.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.37 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.39 | ||
| P/tB | 0.54 | ||
| EV/EBITDA | N/A |
EPS(TTM)-6.64
EYN/A
EPS(NY)-4.32
Fwd EYN/A
FCF(TTM)-3.99
FCFYN/A
OCF(TTM)-3.99
OCFYN/A
SpS15.06
BVpS14.23
TBVpS10.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -29.56% | ||
| ROE | -40.62% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 53.79% | ||
| FCFM | N/A |
ROA(3y)-63.93%
ROA(5y)-45.24%
ROE(3y)-84.79%
ROE(5y)-58.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.48%
GM growth 5Y6.88%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 0.06% | ||
| Cap/Sales | 0.01% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.37 | ||
| Quick Ratio | 3.35 | ||
| Altman-Z | -7.84 |
F-Score6
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)31.54%
Cap/Depr(5y)27.61%
Cap/Sales(3y)3.96%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%45.13%
EPS Next Y34.92%
EPS Next 2Y23.79%
EPS Next 3Y18.72%
EPS Next 5Y11.1%
Revenue 1Y (TTM)-1.98%
Revenue growth 3Y-3.47%
Revenue growth 5Y0.33%
Sales Q2Q%-22.11%
Revenue Next Year-19.18%
Revenue Next 2Y-8.22%
Revenue Next 3Y-4.1%
Revenue Next 5Y-1.6%
EBIT growth 1Y55.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.27%
EBIT Next 3Y24.78%
EBIT Next 5Y16.34%
FCF growth 1Y53.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.21%
OCF growth 3YN/A
OCF growth 5YN/A
AMERICAN WELL CORP-CLASS A / AMWL Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for AMERICAN WELL CORP-CLASS A?
ChartMill assigns a fundamental rating of 3 / 10 to AMWL.
What is the valuation status of AMERICAN WELL CORP-CLASS A (AMWL) stock?
ChartMill assigns a valuation rating of 0 / 10 to AMERICAN WELL CORP-CLASS A (AMWL). This can be considered as Overvalued.
What is the profitability of AMWL stock?
AMERICAN WELL CORP-CLASS A (AMWL) has a profitability rating of 1 / 10.
What is the financial health of AMERICAN WELL CORP-CLASS A (AMWL) stock?
The financial health rating of AMERICAN WELL CORP-CLASS A (AMWL) is 7 / 10.